HIV vaccines and methods of using
TW202631652APending Publication Date: 2026-08-01GILEAD SCIENCES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114145161
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-04-05
- Filing Date
- 2022-01-13
- Publication Date
- 2026-08-01
Abstract
Provided are HIV-1 fusion polypeptides, polynucleotides encoding such fusion polypeptides, vectors expressing such fusion polypeptides for use in eliciting an immune response against HIV-1; pharmaceutical and immunogenic compositions and kits comprising such fusion polypeptides, polynucleotides or vectors, and methods of use in treating and / or preventing HIV-1. Further provided are methods for design of antiviral vaccines, including vaccines to elicit an immune response against HIV-1.
Need to check novelty before this filing date? Find Prior Art